Alkermes plc 21,000,000 Ordinary Shares1 ($0.01 nominal value per share) Underwriting AgreementUnderwriting Agreement • March 13th, 2012 • Elan Corp PLC • Pharmaceutical preparations • New York
Contract Type FiledMarch 13th, 2012 Company Industry JurisdictionElan Science Three Limited (the “Selling Shareholder”), a private limited company incorporated under the laws of Ireland (registered number 477401), proposes to sell, subject to the terms and conditions stated herein, to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the beneficial interest in 21,000,000 ordinary shares, $0.01 nominal value per share (“Ordinary Shares”) of Alkermes plc, a public limited company incorporated under the laws of Ireland (registered number 498284) (the “Company”) (said shares to be sold by the Selling Shareholder being hereinafter called the “Underwritten Securities”). The Selling Shareholder also proposes to grant to the Underwriters an option to purchase up to 3,150,000 additional Ordinary Shares (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To
Linkage Technologies International Holdings Limited 10,200,000 America Depositary Shares Each Representing 102,000,000 Ordinary Shares ($0.01 par value per ordinary share) Underwriting AgreementUnderwriting Agreement • November 25th, 2009 • Linkage Technologies International Holdings LTD • Services-prepackaged software • New York
Contract Type FiledNovember 25th, 2009 Company Industry JurisdictionCitigroup Global Markets Inc. Barclays Capital Inc. As Representatives of the several Underwriters named in Schedule I-A hereto, c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013